A Bioprinted Head and Neck Cancer Organoid-Based Platform for Evaluating Multimodal Therapies
Luda Lin, Krishna K. Bommakanti, Christian Wooten…·Alice Soragni
This paper develops a bioprinted organoid platform to evaluate multimodal therapies for HNSCC, showing differential responses to radiosensitizers in patient-derived models.